Novel therapies for the treatment of non-small cell lung cancer.

David H. Johnson, Joan H. Schiller

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The management of advanced NSCLC remains a daunting challenge. However, new tools are available for treating this malignancy and continued progress is likely. The future is bright with a myriad of opportunities to exploit our ever-expanding knowledge of tumor biology. What is perhaps most needed, however, is development of new methods to prevent children and young adults from ever taking up the use of tobacco. In addition, we need new techniques to assist those who are already addicted to escape from tobacco's death grip. Sadly, most users of tobacco still fail to recognize the dangers of their habit. This needs to change!

Original languageEnglish (US)
Pages (from-to)763-786
Number of pages24
JournalCancer chemotherapy and biological response modifiers
Volume20
StatePublished - 2002

Fingerprint

Non-Small Cell Lung Carcinoma
Tobacco
Tobacco Use
Hand Strength
Habits
Young Adult
Neoplasms
Therapeutics

Cite this

Novel therapies for the treatment of non-small cell lung cancer. / Johnson, David H.; Schiller, Joan H.

In: Cancer chemotherapy and biological response modifiers, Vol. 20, 2002, p. 763-786.

Research output: Contribution to journalArticle

@article{95798a3fd9254649b96f9cf946d6057c,
title = "Novel therapies for the treatment of non-small cell lung cancer.",
abstract = "The management of advanced NSCLC remains a daunting challenge. However, new tools are available for treating this malignancy and continued progress is likely. The future is bright with a myriad of opportunities to exploit our ever-expanding knowledge of tumor biology. What is perhaps most needed, however, is development of new methods to prevent children and young adults from ever taking up the use of tobacco. In addition, we need new techniques to assist those who are already addicted to escape from tobacco's death grip. Sadly, most users of tobacco still fail to recognize the dangers of their habit. This needs to change!",
author = "Johnson, {David H.} and Schiller, {Joan H.}",
year = "2002",
language = "English (US)",
volume = "20",
pages = "763--786",
journal = "Cancer chemotherapy and biological response modifiers",
issn = "0921-4410",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Novel therapies for the treatment of non-small cell lung cancer.

AU - Johnson, David H.

AU - Schiller, Joan H.

PY - 2002

Y1 - 2002

N2 - The management of advanced NSCLC remains a daunting challenge. However, new tools are available for treating this malignancy and continued progress is likely. The future is bright with a myriad of opportunities to exploit our ever-expanding knowledge of tumor biology. What is perhaps most needed, however, is development of new methods to prevent children and young adults from ever taking up the use of tobacco. In addition, we need new techniques to assist those who are already addicted to escape from tobacco's death grip. Sadly, most users of tobacco still fail to recognize the dangers of their habit. This needs to change!

AB - The management of advanced NSCLC remains a daunting challenge. However, new tools are available for treating this malignancy and continued progress is likely. The future is bright with a myriad of opportunities to exploit our ever-expanding knowledge of tumor biology. What is perhaps most needed, however, is development of new methods to prevent children and young adults from ever taking up the use of tobacco. In addition, we need new techniques to assist those who are already addicted to escape from tobacco's death grip. Sadly, most users of tobacco still fail to recognize the dangers of their habit. This needs to change!

UR - http://www.scopus.com/inward/record.url?scp=0037977753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037977753&partnerID=8YFLogxK

M3 - Article

C2 - 12703233

AN - SCOPUS:0037977753

VL - 20

SP - 763

EP - 786

JO - Cancer chemotherapy and biological response modifiers

JF - Cancer chemotherapy and biological response modifiers

SN - 0921-4410

ER -